Search clinical trials for: CAM2038 q1w or q4w exposure to SL BPN/NX

Total 2 results

Braeburn Pharmaceuticals

Completed

Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use Disorder

Opioid Use Disorder

United States, United Kingdom, Taiwan, Hungary, Australia, Denmark, Germany, Sweden
Braeburn Pharmaceuticals

Completed

Clinical Trial of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of Patients With Opioid Dependence

Opioid Use Disorders

United States

3

Subscribe